2015•Unpublished venueRequires access

Analysis of phosphate West Gulliver Ding combined with metformin in the treatment of type 2 diabetes mellitus

LI Xiaoton

Open publisher page 0 citations

Abstract

Objective To analyze sitagliptin phosphate with metformin treatment of type 2 diabetes. Methods 60 patients with type2 diabetes were randomly divided into experimental and control groups, the control group patients were treated with metformin,sitagliptin phosphate patients in the experimental group therapy on the basis of the control group. Comparison of the two groups of patients. Treatment observation group than the control group, the difference was statistically significant(P0.05). Conclusions Sitagliptin phosphate with metformin treatment of type 2 diabetes significant effect, complication rate, worthy of clinical application.

About this research paper

What this paper is about

Objective To analyze sitagliptin phosphate with metformin treatment of type 2 diabetes. Methods 60 patients with type2 diabetes were randomly divided into experimental and control groups, the control group patients were treated with metformin,sitagliptin phosphate patients in the experimental group therapy on the basis of the control group. Comparison of the two groups of patients. Treatment observation group than the control group, the difference was statistically significant(P0.05). Conclusions Sitagliptin phosphate with metformin treatment of type 2 diabetes significant effect, complication rate, worthy of clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze sitagliptin phosphate with metformin treatment of type 2 diabetes. Methods 60 patients with type2 diabetes were randomly divided into experimental and control groups, the control group patients were treated with metformin,sitagliptin phosphate patients in the experimental group therapy on the basis of the control group. Comparison of the two groups of patients. Treatment observation group than the control group, the difference was statistically significant(P0.05). Conclusions Sitagliptin phosphate with metformin treatment of type 2 diabetes significant effect, complication rate, worthy of clinical application.

Key concepts: Metformin, Sitagliptin, Sitagliptin Phosphate, Medicine, Diabetes mellitus, Type 2 diabetes, Internal medicine, Phosphate

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of phosphate West Gulliver Ding combined with metformin in the treatment of type 2 diabetes mellitus — Research Paper | ScholarLens